Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
 
CASE REPORT
Ahead of Print

Novel coronavirus infection (COVID-19) in a 12-year-old boy with acute lymphoblastic leukemia


1 Department of Pediatrics, Hematology-Oncologym Division, Faculty of Medicine, Ulin General Hospital, Lambung Mangkurat University, Banjarmasin, South Kalimantan, Indonesia
2 Department of Pediatrics of Doris Sylvanus Hospital, Palangkaraya, Central Kalimantan, Indonesia
3 Department of Pediatrics of Ulin General Hospital, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, South Kalimantan, Indonesia

Correspondence Address:
Wulandewi Marhaeni,
Department of Pediatrics of Ulin General Hospital, Faculty of Medicine, Lambung Mangkurat University, Banjarmasin, South Kalimantan
Indonesia
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/jcrt.JCRT_653_20

Pediatric acute lymphoblastic leukemia (ALL) with COVID-19 might still have a risk of severe infection due to immunocompromised condition. The clinical features in oncology population are quite similar to those of previous reports in general pediatric cases. Chemotherapy should be arranged individually to balance the risk between leukemia progressivity itself and COVID-19 complications. Interruptions of therapy must be thought in cases with severe or symptomatic infection of severe acute respiratory syndrome-CoV-2. In this case report, chemotherapy will be started 1 week after the improvement of general condition. Chemotherapy should not be postponed for >14 days.


Print this article
Search
 Back
 
  Search Pubmed for
 
    -  Marhaeni W
    -  Abdiwati NM
    -  Wijaya AB
 Citation Manager
 Article Access Statistics
 Reader Comments
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed811    
    PDF Downloaded16    

Recommend this journal